Position in LTRN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,184,275
-$1,874,531 QoQ
Shares Held
864,435
-14.4% QoQ
Ownership
7.65%
of shares outstanding
% of Portfolio
2.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LTRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BIOS Capital Management, LP holds $52,866,301 across 6 Biotechnology names. LTRN ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACTU |
Actuate Therapeutics, Inc.
|
10,049,996 | $27,536,988 | |
| 2 | IRD |
Opus Genetics, Inc.
|
3,683,429 | $16,759,601 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
6,000,000 | $4,559,999 | |
| 4 | RNTX |
Rein Therapeutics, Inc.
|
1,982,375 | $2,577,087 | |
| 5 | LTRN |
Lantern Pharma Inc.
This page
|
864,435 | $1,184,275 | |
| 6 | INAB |
In8bio, Inc.
|
167,805 | $248,351 |
All Filings in LTRN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,184,275 | 864,435 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $3,058,806 | 1,009,507 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $4,418,360 | 1,015,715 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $3,400,008 | 1,075,952 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $4,275,289 | 1,207,709 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $3,852,591 | 1,207,709 | Shares | Other | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||